METFORMIN\ROSIGLITAZONE: 4,637 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
4,637
Total FAERS Reports
395 (8.5%)
Deaths Reported
3,271
Hospitalizations
4,637
As Primary/Secondary Suspect
1
Life-Threatening
7
Disabilities
Active Ingredient: METFORMIN HYDROCHLORIDE\ROSIGLITAZONE MALEATE ·
First Report: 19940110 · Latest Report: 201312
What Are the Most Common METFORMIN\ROSIGLITAZONE Side Effects?
#1 Most Reported
Myocardial infarction
1,640 reports (35.4%)
#2 Most Reported
Cardiac failure congestive
1,408 reports (30.4%)
#3 Most Reported
Cerebrovascular accident
750 reports (16.2%)
All METFORMIN\ROSIGLITAZONE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Myocardial infarction | 1,640 | 35.4% | 211 | 1,179 |
| Cardiac failure congestive | 1,408 | 30.4% | 129 | 985 |
| Cerebrovascular accident | 750 | 16.2% | 56 | 522 |
| Coronary artery disease | 738 | 15.9% | 61 | 661 |
| Acute myocardial infarction | 351 | 7.6% | 41 | 324 |
| Coronary arterial stent insertion | 245 | 5.3% | 6 | 170 |
| Coronary artery bypass | 181 | 3.9% | 3 | 164 |
| Chest pain | 160 | 3.5% | 1 | 122 |
| Hypertension | 139 | 3.0% | 7 | 89 |
| Atrial fibrillation | 117 | 2.5% | 14 | 106 |
| Angina unstable | 116 | 2.5% | 1 | 112 |
| Myocardial ischaemia | 111 | 2.4% | 11 | 88 |
| Cardiac disorder | 103 | 2.2% | 15 | 61 |
| Angina pectoris | 86 | 1.9% | 3 | 77 |
| Transient ischaemic attack | 82 | 1.8% | 5 | 75 |
| Acute coronary syndrome | 73 | 1.6% | 5 | 66 |
| Cardiac arrest | 69 | 1.5% | 54 | 46 |
| Cardio-respiratory arrest | 68 | 1.5% | 63 | 38 |
| Cardiomyopathy | 63 | 1.4% | 10 | 55 |
| Arteriosclerosis coronary artery | 58 | 1.3% | 14 | 51 |
Who Reports METFORMIN\ROSIGLITAZONE Side Effects? Age & Gender Data
Gender: 41.4% female, 58.6% male. Average age: 58.2 years. Most reports from: COUNTRY NOT SPECIFIED. View detailed demographics →
Is METFORMIN\ROSIGLITAZONE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2000 | 34 | 2 | 32 |
| 2001 | 46 | 2 | 45 |
| 2002 | 69 | 4 | 65 |
| 2003 | 145 | 7 | 131 |
| 2004 | 261 | 11 | 249 |
| 2005 | 381 | 22 | 353 |
| 2006 | 391 | 34 | 359 |
| 2007 | 470 | 60 | 414 |
| 2008 | 432 | 41 | 387 |
| 2009 | 415 | 65 | 357 |
| 2010 | 427 | 55 | 381 |
| 2011 | 131 | 17 | 115 |
| 2012 | 26 | 7 | 19 |
| 2013 | 5 | 0 | 3 |
What Is METFORMIN\ROSIGLITAZONE Used For?
| Indication | Reports |
|---|---|
| Diabetes mellitus | 4,438 |
| Type 2 diabetes mellitus | 105 |
| Product used for unknown indication | 26 |
METFORMIN\ROSIGLITAZONE vs Alternatives: Which Is Safer?
METFORMIN\ROSIGLITAZONE vs METFORMIN\SAXAGLIPTIN
METFORMIN\ROSIGLITAZONE vs METFORMIN\SITAGLIPTIN
METFORMIN\ROSIGLITAZONE vs METFORMIN\VILDAGLIPTIN
METFORMIN\ROSIGLITAZONE vs METHADONE
METFORMIN\ROSIGLITAZONE vs METHAMPHETAMINE
METFORMIN\ROSIGLITAZONE vs METHENAMINE HIPPURATE
METFORMIN\ROSIGLITAZONE vs METHIMAZOLE
METFORMIN\ROSIGLITAZONE vs METHOCARBAMOL
METFORMIN\ROSIGLITAZONE vs METHOHEXITAL
METFORMIN\ROSIGLITAZONE vs METHOTREXATE
Official FDA Label for METFORMIN\ROSIGLITAZONE
Official prescribing information from the FDA-approved drug label.